Diagnosis of ovarian quiescence were made in five Holstein heifers by repeated rectal palpations on the basis of the absence of corpus luteum (CL) and abnormal follicle in the ovaries. The heifers were treated with 750-3, 000 IU of human chorionic gonadotrophin (hCG). When the treatment failed to induce the ovarian cyclic activity, second and third treatments were conducted with 2-4 times dosages of the hormone 25-26 days and 59 days, respectively, after the preceding treatment. A total of 11 cases of treatment were obtained from the five heifers. They were divided into four groups, I-IV, according to the dosage. Group I, II and III consisted of 3 cases each and received a single intra-muscular (IM) injection of 750, 1, 500 and 3, 000 IU of hCG, respectively. Group IV consisted of 2 cases and received a single IM injection of 6, 000 IU of hCG. Mean age was 18.2±2.7 (SD) months and mean weight 337.1±21.8 kg at the time of treatment in the 11 cases. Ovarian changes were traced by rectal palpations at intervals of 6 hr to 2 days during the experimental period extending from 6-7 days before to 25-46 days after the treatment. Plasma progesterone (P) and estradiol-17β (E
2) concentra-tions were determined by radioimmunoassay on samples collected at intervals of 12-48 hr during the experimental period.
The following results were obtained.
1. Ovulations were induced 37.8±2.7 hr after hCG treatment in 10 cases (90.9%). Second ovula-tions occurred spontaneously 9, 10 and 15 days after the induced ovulation (ind. OV) in one case each of Groups II, IV and III, respectively. The normal ovarian function began in these 3 cases thereafter. In the other 7 cases no second ovulation occurred and ovarian quiescence resulted again. In the remaining case of Group I, the ovaries continued to be quiescent, no ovulation being induced.
2. Corpora lutea developed after ind. OV (i.e. induced CL) in all the 10 cases. They were classi-fied into 2 types. One type was subnormal in size (<18 mm in diameter), accompanied with a small P rise (3.2±1.4 ng/m
l), and degenerated as early as 5-8 days after ind. OV. The other type was generally normal in size ( ?? 18 mm in diameter), went with an obvious high P peak (8.5±3.3 ng/m
l), and began to degenerate relatively early, or 10-12 days after ind. OV. A well-formed induced CL appeared frequently as the dosage was increased from 750 to 3, 000 IU. Average P peaks accompany-ing the formation of induced CL tended to be enhanced according to an increase in dosage, being 2.3±0.7, 4.1±2.9, 6.9±4.1, and 7.9±4.2 ng/m
l in Groups I, II, III and IV, respectively.
3. Follicles developed in each of the 10 cases during the degeneration of the induced CL. They ovulated in 3 cases in which sharp E
2 peaks were observed with the advance of follicular development and maturation. In the other 7 cases, no E
2 rise was observed with the advance of follicular develop-ment and then follicles became atrophic.
4. Second spontaneous ovulations occurred and then the ovaries began to show their normal func-tion in 3 cases. In them P increased in blood level in coincidence with the formation of induced CL and E2 increased sharply in blood level with the follicular development and maturation accompanying the degeneration of induced CL.
These results indicate that (1) the ovarian response was more remarkable to the dosage of hCG of 1, 500 IU or over than to that of 750 IU. (2) It was found necessary for ovarian activation following hCG treatment that the induced CL had to be functional enough to exhibit a P peak in plasma and that a follicle had to develop and mature, secreting E2 actively with the degeneration of the induced CL. (3) It was also recognized that ovarian activation following hCG treatment was not always achieved only by the good development and sufficient P-secreting function of induced CL.
View full abstract